In particular, IL-33-mediated T cell responses and 5-FU treatment also increased the secretion of the T cell chemokines CXCL10 and CXCL13 by CRC cells in a synergistic manner in the in vitro setting (Figure 7F-G). The gene discussed is IL33; the disease is colorectal carcinoma.